KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Other Non-Current Liabilities (2016 - 2026)

Bristol Myers Squibb has reported Other Non-Current Liabilities over the past 18 years, most recently at $4.9 billion for Q1 2026.

  • Quarterly Other Non-Current Liabilities rose 8.4% to $4.9 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $4.9 billion through Mar 2026, up 8.4% year-over-year, with the annual reading at $5.0 billion for FY2025, 12.84% up from the prior year.
  • Other Non-Current Liabilities was $4.9 billion for Q1 2026 at Bristol Myers Squibb, down from $5.0 billion in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $7.3 billion in Q1 2022 and troughed at $4.5 billion in Q4 2024.
  • The 5-year median for Other Non-Current Liabilities is $5.9 billion (2023), against an average of $5.8 billion.
  • The largest YoY upside for Other Non-Current Liabilities was 15.46% in 2025 against a maximum downside of 33.5% in 2025.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $6.6 billion in 2022, then fell by 2.56% to $6.4 billion in 2023, then crashed by 30.4% to $4.5 billion in 2024, then increased by 12.84% to $5.0 billion in 2025, then fell by 3.77% to $4.9 billion in 2026.
  • Per Business Quant, the three most recent readings for BMY's Other Non-Current Liabilities are $4.9 billion (Q1 2026), $5.0 billion (Q4 2025), and $5.5 billion (Q3 2025).